Moomoo AI 已提取核心信息
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 1,879 shares of common stock on February 5, 2024. The transaction was carried out in the open market with a sale price of $0.9025 per share, resulting in a total value of approximately $1,695.80. Following the sale, Obenshain's direct holdings in the company amount to 286,093 shares of common stock.
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 1,879 shares of common stock on February 5, 2024. The transaction was carried out in the open market with a sale price of $0.9025 per share, resulting in a total value of approximately $1,695.80. Following the sale, Obenshain's direct holdings in the company amount to 286,093 shares of common stock.
蓝鸟生物公司总裁兼首席执行官安德鲁·奥本沙因于2024年2月5日完成了1,879股普通股的出售。该交易在公开市场上进行，出售价格为每股0.9025美元，总价值约为1,695.80美元。出售后，Obenshain在该公司的直接持有量为286,093股普通股。
蓝鸟生物公司总裁兼首席执行官安德鲁·奥本沙因于2024年2月5日完成了1,879股普通股的出售。该交易在公开市场上进行，出售价格为每股0.9025美元，总价值约为1,695.80美元。出售后，Obenshain在该公司的直接持有量为286,093股普通股。
有用
没用